Bayer Group
Stockholders' Newsletter
Bayer continues on path of growth in third quarter
Bayer continued on its path of growth in the third quarter of 2008. Sales rose by 2.0 percent to €7,948 million (q3 2007: €7,793 million). Adjusted for currency and portfolio effects, sales rose by 5.1 percent. HealthCare improved sales by 6.1 percent. Sales of CropScience gained a substantial 14.0 percent. Business of MaterialScience was at the previous year’s level (-0.5 percent) in a difficult market environment. external link: » more
4:01 min.
4:01 min.